Open Synthesis Network

Title Open Synthesis Network
The Indian Institute of Technology Gandhinagar in Ahmedabad, India; the Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management at Narsee Monjee Institute of Management Studies (NMIMS) in Mumbai, India; the Indian Institute of Chemical Technology (IICT) in Hyderabad, India; Imperial College London, UK; Northeastern University in Boston, USA; and Pace University in New York City, USA.
Target disease Visceral leishmaniasis
Time frame 2016 – 2017

The NTD Drug Discovery Booster

Title The NTD Drug Discovery Booster
Partners Eisai Co., Ltd; Shionogi & Co Ltd; Takeda Pharmaceutical Limited; AstraZeneca plc; Celgene Corporation; Merck
Target disease Chagas Disease and Leishmaniasis
Time frame From 2015-2018 with the possibility of extension & expansion

The Pathogen Box

Title The Pathogen Box
Partners Medicines for Malaria Venture (MMV) & partners
Target disease Ascariasis, Buruli ulcer, Chagas, Cryptosporidiosis, Hookworm, Human African Trypanosomiasis, Viceral & Cutaneous Leishmaniasis, Lymphatic Filariasis, Malaria, Onchocerciasis, Schistosomiasis, Trichuriasis, Tuberculosis
Time frame From 2014 and ongoing

MMV Malaria Box

DNDi Screening of the MMV Open Access Malaria Box for HAT, VL, and Chagas disease

Title Screening of the MMV Open Access Malaria Box in the search for new drugs against Human African Trypanosomiasis (HAT), visceral leishmaniasis and Chagas disease.
Partners Medicines for Malaria Venture (MMV); University of Antwerp (LMPH)
Target disease Human African Trypanosomiasis (HAT); visceral leishmaniasis; Chagas disease
Time frame February 2012 – April 2012